Home › Companies › Wave Life Sciences Ltd. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Wave Life Sciences Ltd.’s Form 8-K, filed August 11, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of August 5, 2025: 14 items on Wave Life Sciences Ltd.’s Form 8-K, filed August 11, 2025: 5 approved · 9 passed (calculated).
Notable dissent: 1 director (14.6% against); 1 equity or compensation plan (18.9% against); 1 other board item (21.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13D, 16.8%, as of August 11, 2026)
Explore Wave Life Sciences Ltd. in the interactive database Compare manager voting policies
These tallies are Wave Life Sciences Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 11, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Paul B. Bolno, M.D., MBA | 129,131,201 | 1,501,235 | 8,680 | -- | 14,529,462 | 99% | Passed (calculated) | — |
| Elect Director: Mark H.N. Corrigan, M.D. | 129,548,443 | 1,084,930 | 7,743 | -- | 14,529,462 | 99.2% | Passed (calculated) | — |
| Elect Director: Christian Henry | 111,549,230 | 19,074,532 | 17,354 | -- | 14,529,462 | 85% | Passed (calculated) | — |
| Elect Director: Peter Kolchinsky, Ph.D. | 130,188,145 | 444,723 | 8,248 | -- | 14,529,462 | 99.7% | Passed (calculated) | — |
| Elect Director: Adrian Rawcliffe | 130,337,320 | 285,647 | 18,149 | -- | 14,529,462 | 99.8% | Passed (calculated) | — |
| Elect Director: Ken Takanashi | 124,467,167 | 6,024,248 | 149,701 | -- | 14,529,462 | 95% | Passed (calculated) | — |
| Elect Director: Aik Na Tan | 130,362,062 | 269,697 | 9,357 | -- | 14,529,462 | 99.8% | Passed (calculated) | — |
| Elect Director: Gregory L. Verdine, Ph.D. | 130,098,845 | 521,198 | 21,073 | -- | 14,529,462 | 99.6% | Passed (calculated) | — |
| Elect Director: Heidi L. Wagner, J.D. | 125,980,141 | 4,281,064 | 379,911 | -- | 14,529,462 | 97% | Passed (calculated) | — |
| 2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix | 144,541,282 | 619,542 | 9,754 | -- | 0 | 99.6% | Approved | — |
| 3. Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final vo | 130,474,503 | 155,613 | 11,000 | -- | 14,529,462 | 99.9% | Approved | — |
| 4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast | 105,936,049 | 24,647,485 | 57,582 | -- | 14,529,462 | 81% | Approved | — |
| 5. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast | 102,173,940 | 28,413,704 | 53,472 | -- | 14,529,462 | 78% | Approved | — |
| 6. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast | 129,648,036 | 977,466 | 15,614 | -- | 14,529,462 | 99.3% | Approved | — |
Source: Wave Life Sciences Ltd., Form 8-K, filed with the SEC on August 11, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
198 asset managers disclosed a vote on at least one Wave Life Sciences Ltd. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Wave Life Sciences Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held August 5, 2025.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Prior year: 99.7% for (August 6, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: The election of the nominees for director: Adrian Rawcliffe
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Adrian Rawcliffe”): 130,337,320 for, 285,647 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,274,133 for, 437 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Prior year: 99.7% for (August 6, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: The election of the nominees for director: Aik Na Tan
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Aik Na Tan”): 130,362,062 for, 269,697 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,274,570 for, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Prior year: 85.3% for (August 6, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: The election of the nominees for director: Christian Henry
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Christian Henry”): 111,549,230 for, 19,074,532 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 14,948,481 for, 13,326,089 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 5,059,945 | 0 | 0 | Against |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 0 | 3,171,588 | 0 | 0 | Against |
| Fidelity | 2,794,949 | 46,751 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,977,032 | 0 | 0 | Against |
| Loomis Sayles | 0 | 1,812,031 | 0 | 0 | Against |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 147,657 | 361,444 | 0 | 0 | Mixed |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 20,377 | 230,218 | 0 | 0 | Mixed |
| Global X | 0 | 246,659 | 0 | 0 | Against |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 181,521 | 0 | 0 | Against |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Prior year: 99.2% for (August 6, 2024 meeting) ▲ 0.4 pts
Description as filed by funds: The election of the nominees for director: Gregory L. Verdine, Ph.D.
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Gregory L. Verdine, Ph.D.”): 130,098,845 for, 521,198 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,245,074 for, 29,496 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 96.6% for (August 6, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: The election of the nominees for director: Heidi L. Wagner, J.D.
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Heidi L. Wagner, J.D.”): 125,980,141 for, 4,281,064 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 27,284,889 for, 749,681 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 0 | 296,459 | 0 | 0 | Against |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 0 | 246,659 | 0 | 0 | Against |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 11,768 | 73,500 | 0 | 0 | Mixed |
| Delaware/Macquarie | 0 | 81,955 | 0 | 0 | Against |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 89.5% for (August 6, 2024 meeting) ▲ 5.8 pts
Description as filed by funds: The election of the nominees for director: Ken Takanashi
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Ken Takanashi”): 124,467,167 for, 6,024,248 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 23,838,161 for, 4,436,409 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,977,032 | 0 | 0 | Against |
| Loomis Sayles | 0 | 1,812,031 | 0 | 0 | Against |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 147,657 | 361,444 | 0 | 0 | Mixed |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 0 | 246,659 | 0 | 0 | Against |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 99.5% for (August 6, 2024 meeting) ▼ 0.3 pts
Description as filed by funds: The election of the nominees for director: Mark H. N. Corrigan, M.D.
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Mark H.N. Corrigan, M.D.”): 129,548,443 for, 1,084,930 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,274,133 for, 437 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.7% for (August 6, 2024 meeting) ▼ 0.8 pts
Description as filed by funds: The election of the nominees for director: Paul B. Bolno, M.D., MBA
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Paul B. Bolno, M.D., MBA”): 129,131,201 for, 1,501,235 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,274,570 for, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Prior year: 99.7% for (August 6, 2024 meeting) unchanged
Description as filed by funds: The election of the nominees for director: Peter Kolchinsky, Ph.D.
Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Peter Kolchinsky, Ph.D.”): 130,188,145 for, 444,723 against, per its Form 8-K filed August 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,274,570 for, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 252,000 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held June 22, 2026; no official results are on file for this meeting.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave- Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave- Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders.
The 58 asset managers below reported 37,821,859 for, 16,522 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 6,970,078 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,239,907 | 0 | 0 | 0 | For |
| Fidelity | 6,072,674 | 0 | 0 | 0 | For |
| Federated Hermes | 3,956,251 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 3,839,708 | 0 | 0 | 0 | For |
| Vanguard | 2,800,796 | 0 | 0 | 0 | For |
| Charles Schwab | 1,179,438 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 954,004 | 0 | 0 | 0 | For |
| State Street | 648,661 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 575,215 | 0 | 0 | 0 | For |
| TIAA | 506,940 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 437,881 | 0 | 0 | 0 | For |
| Equitable | 334,279 | 0 | 0 | 0 | For |
| Dimensional | 321,412 | 0 | 0 | 0 | For |
| Principal | 313,073 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 227,083 | 0 | 0 | 0 | For |
| Brighthouse | 215,274 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 201,259 | 0 | 0 | 0 | For |
| Prudential/PGIM | 191,784 | 0 | 0 | 0 | For |
| JPMorgan | 178,682 | 0 | 0 | 0 | For |
| Jackson National | 163,767 | 0 | 0 | 0 | For |
| Global X | 120,936 | 0 | 0 | 0 | For |
| Invesco | 116,270 | 0 | 0 | 0 | For |
| Nuveen | 110,929 | 0 | 0 | 0 | For |
| Transamerica | 110,824 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Meeting held August 5, 2025.
78% Approved · of votes cast
Description as filed by funds: To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.
Wave Life Sciences Ltd.’s own tally for this item (“5. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 102,173,940 for, 28,413,704 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5 - Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Wave Life Sciences Ltd.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approve Issuance of Shares without Preemptive Rights” (3 managers, 396,729 for).
The 55 asset managers below reported 25,699,836 for, 1,927,343 against, 16,819 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,555,850 | 504,095 | 0 | 0 | Mixed |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,393,154 | 7,841 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 415,144 | 33,138 | 0 | 0 | Mixed |
| State Street | 0 | 296,459 | 0 | 0 | Against |
| Equitable | 191,215 | 59,380 | 0 | 0 | Mixed |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 0 | 218,371 | 0 | 0 | Against |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 0 | 186,213 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 110,769 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 81,955 | 0 | 0 | Against |
| Lincoln Financial | 0 | 73,500 | 0 | 0 | Against |
| John Hancock | 28,868 | 38,681 | 0 | 0 | Mixed |
| GuideStone | 0 | 66,693 | 0 | 0 | Against |
Showing the 25 largest of 55 asset managers. All 55 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non-Employee Directors' Compensation" in the proxy statement.
Wave Life Sciences Ltd.’s own tally for this item (“3. The Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy”): 130,474,503 for, 155,613 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Shareholders approved the Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follow…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 28,078,642 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 3 wordings of this item as funds reported it.
81% Approved · of votes cast
Prior year: 87.1% for (August 6, 2024 meeting) ▼ 6.0 pts
Description as filed by funds: To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement.
Wave Life Sciences Ltd.’s own tally for this item (“4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 105,936,049 for, 24,647,485 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 - Shareholders approved the amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Wave Life Sciences Ltd.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (3 managers, 396,729 against).
The 56 asset managers below reported 26,927,881 for, 727,825 against, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,393,154 | 7,841 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 415,144 | 33,138 | 0 | 0 | Mixed |
| State Street | 296,459 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 0 | 186,213 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 110,769 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 81,955 | 0 | 0 | Against |
| Lincoln Financial | 73,500 | 0 | 0 | 0 | For |
| John Hancock | 28,868 | 38,681 | 0 | 0 | Mixed |
| GuideStone | 0 | 66,693 | 0 | 0 | Against |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Meeting held August 5, 2025.
Combines 5 wordings of this item as funds reported it.
99.3% Approved · of votes cast
Prior year: 99.6% for (August 6, 2024 meeting) ▼ 0.4 pts
Description as filed by funds: To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement
Wave Life Sciences Ltd.’s own tally for this item (“6. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast”): 129,648,036 for, 977,466 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 6 - Shareholders approved on a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast as follows:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
Fund voting reports, all 55 managers: 28,009,679 for, 12,891 against, 18,157 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 18,202,009 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 14,462,384 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 6,541,967 | 0 | 0 | 0 | For |
| M28 Capital Management LP | 5,664,548 | 0 | 0 | 0 | For |
| PRIMECAP MANAGEMENT CO/CA/ | 4,957,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,917,668 | 0 | 0 | 0 | For |
| BlackRock | 4,727,302 | 9,277 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,352,886 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 3,425,335 | 0 | 0 | 0 | For |
| Loomis Sayles | 3,250,218 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 3,155,227 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,615,926 | 0 | 0 | 0 | For |
| State Street | 2,264,331 | 294 | 0 | 0 | For |
| Artisan | 2,055,536 | 0 | 0 | 0 | For |
| Charles Schwab | 2,033,238 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 2,007,000 | 0 | 0 | 0 | For |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,937,066 | 0 | 0 | 0 | For |
| EMERALD ADVISERS, LLC | 1,773,503 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 1,505,262 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 1,305,356 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 1,123,100 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 900,000 | 0 | 0 | 0 | For |
| Northern Trust | 767,592 | 0 | 0 | 0 | For |
| PLATINUM INVESTMENT MANAGEMENT LTD | 657,486 | 0 | 0 | 0 | For |
| Fidelity | 516,930 | 0 | 0 | 0 | For |
Institutional-manager reports, all 152 managers: 101,136,601 for, 296,114 against, 940 not voted, 42,048 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held August 5, 2025.
Combines 4 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS ONLY, THE FREQUENCY OF HOLDING FUTURE SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| PRIMECAP Odyssey Funds | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Loomis Sayles | 0 | 0 | 0 | 0 | -- |
| Principal | 0 | 0 | 0 | 0 | -- |
| RBB FUND, INC. | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 448,282 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| OPTIMUM FUND TRUST | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| GuideStone | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 54 managers: 448,282 for, 6,157 abstained, 27,177,559 1 year, 12,000 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| MAVERICK CAPITAL LTD | 0 | 0 | 0 | 0 | -- |
| M28 Capital Management LP | 0 | 0 | 0 | 0 | -- |
| PRIMECAP MANAGEMENT CO/CA/ | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| BlackRock | 868,754 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| 683 Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Loomis Sayles | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Artisan | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | -- |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0 | 0 | 0 | 0 | -- |
| EMERALD ADVISERS, LLC | 0 | 0 | 0 | 0 | -- |
| MPM BioImpact LLC | 0 | 0 | 0 | 0 | -- |
| Kynam Capital Management, LP | 1,305,356 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 150 managers: 2,251,912 for, 940 not voted, 93,582,822 1 year, 314,256 3 year, 15,000 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held August 5, 2025.
Combines 2 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2026 Annual General Meeting of Shareholders.
Wave Life Sciences Ltd.’s own tally for this item (“2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of t”): 144,541,282 for, 619,542 against — passed, per its Form 8-K filed August 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Shareholders approved the re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuner…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 28,034,570 for, 6,157 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,059,945 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,529,395 | 0 | 0 | 0 | For |
| Vanguard | 3,171,588 | 0 | 0 | 0 | For |
| Fidelity | 2,841,700 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 2,378,380 | 0 | 0 | 0 | For |
| Charles Schwab | 1,977,032 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,812,031 | 0 | 0 | 0 | For |
| Principal | 1,400,995 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,329,191 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 916,023 | 0 | 0 | 0 | For |
| Brighthouse | 509,101 | 0 | 0 | 0 | For |
| JPMorgan | 324,142 | 0 | 0 | 0 | For |
| State Street | 296,459 | 0 | 0 | 0 | For |
| Equitable | 250,595 | 0 | 0 | 0 | For |
| Global X | 246,659 | 0 | 0 | 0 | For |
| TIAA | 218,371 | 0 | 0 | 0 | For |
| Prudential/PGIM | 197,329 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 186,213 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 181,521 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 172,731 | 0 | 0 | 0 | For |
| Jackson National | 124,776 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 110,769 | 0 | 0 | 0 | For |
| Lincoln Financial | 85,268 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 81,955 | 0 | 0 | 0 | For |
| John Hancock | 67,549 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 155,673,292 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.48% |
| 2 | T. Rowe Price | 4.01% |
| 3 | Fidelity | 3.90% |
| 4 | Federated Hermes | 2.54% |
| 5 | PRIMECAP Odyssey Funds | 2.47% |
| 6 | Vanguard | 1.80% |
| 7 | Charles Schwab | 0.76% |
| 8 | DRIEHAUS MUTUAL FUNDS | 0.61% |
| 9 | State Street | 0.42% |
| 10 | RBB FUND, INC. | 0.37% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 11.69% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 9.29% |
| 3 | MAVERICK CAPITAL LTD | 4.20% |
| 4 | M28 Capital Management LP | 3.64% |
| 5 | PRIMECAP MANAGEMENT CO/CA/ | 3.18% |
| 6 | T. Rowe Price | 3.16% |
| 7 | BlackRock | 3.04% |
| 8 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.80% |
| 9 | 683 Capital Management, LLC | 2.20% |
| 10 | Loomis Sayles | 2.09% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| RA Capital Management, L.P. | 34,314,406 | 22.04% | Schedule 13D, filed August 11, 2026 |
| BlackRock | 14,117,412 | 9.07% | Form 13F, quarter ended March 31, 2026 |
| T. Rowe Price | 8,704,550 | 5.59% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 5,192,761 | 3.34% | Form 13F, quarter ended March 31, 2026 |
| State Street | 3,674,033 | 2.36% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 3,579,099 | 2.30% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 3,573,746 | 2.30% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 2,818,156 | 1.81% | Form 13F, quarter ended March 31, 2026 |
| Two Sigma | 1,878,115 | 1.21% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,383,590 | 0.89% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 155,673,292 shares outstanding, as reported by Wave Life Sciences Ltd. on its Form 10-Q dated June 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Wave Life Sciences Ltd.'s 2 shareholder meetings in the 2025-2026 proxy season (held August 5, 2025 and June 22, 2026), 198 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 3,417 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held August 5, 2025 — To approve, by a non-binding advisory vote, the compensation of our named executive officers as… — Wave Life Sciences Ltd.'s filing reports the proposal as approved, with 99.3% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Wave Life Sciences Ltd.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 11, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Wave Life Sciences Ltd.’s 10-Q dated June 30, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Wave Life Sciences Ltd. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Wave Life Sciences (WVE) 2025-2026 Annual & Special Meetings”, https://proxyvotesnow.com/company/wave-life-sciences-ltd/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.